Aged Fischer 344 rats exhibit altered locomotion in the absence of decreased locomotor activity: Exacerbation by nomifensine

Neuroscience Letters

Volumn 333, Issue 3, 2002, Pages 195-198

  Stanford, John A ^a,c   Vorontsova, Elena ^b   Surgener, Stewart P ^a   Gerhardt, Greg A ^a   Fowler, Stephen C ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Basal ganglia; Dopamine; Gait; Movement

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; NOMIFENSINE;

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; FORCE; GAIT; GROUPS BY AGE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; AGE FACTORS; AGING; ANALYSIS OF VARIANCE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAIT; HOMOVANILLIC ACID; LOCOMOTION; MALE; NOMIFENSINE; RATS; RATS, INBRED F344; RATS, INBRED STRAINS; SUBSTANTIA NIGRA; TIME FACTORS;

EID: 0037195539     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01105-9     Document Type: Article

References (20)

1. Bennett D.A., Beckett L.A., Murray A.M., Shannon K.M., Goetz C.G., Pilgrim D.M., Evans D.A. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N. Engl. J. Med. 334:1996;71-76.
2. Campbell J.M., Payne A.P., Gilmore D.P., Byrne J.E., Russell D., McGadey J., Clarke D.J., Davies R.W., Sutcliffe R.G. Neostriatal dopamine depletion and locomotor abnormalities due to the Albino Swiss rat agu mutation. Neurosci. Lett. 213:1996;173-176.
3. Dorner H., Otte P., Platt D. Training influence on age-dependent changes in the gait of rats. Gerontology. 42:1996;7-13.
4. Emerich D.F., McDermott P., Krueger P., Banks M., Zhao J., Marszalkowski J., Frydel B., Winn S.R., Sanberg P.R. Locomotion of aged rats: relationship to neurochemical but not morphological changes in nigrostriatal dopaminergic neurons. Brain Res. Bull. 32:1993;477-486.
5. Eshuis S.A., Leenders K.L. Parkinson's disease: symptoms and age dependency. Hof R.P., Mobbs C.V., Functional Neurobiology of Aging. 2001;675-688 Academic Press, San Diego, CA.
6. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., Zarcone T.J. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J. Neurosci. Methods. 107:(1-2):2001;107-124.
7. Hall M.E., Hoffer B.J., Gerhardt G.A. Rapid and sensitive determination of catecholamines in small tissue samples by high performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection. LC-GC. 7:(3):1989;258-265.
8. Hebert M.A., Gerhardt G.A. Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats. Brain Res. 797:1998;42-54.
9. Hoffman A.F., Gerhardt G.A. Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. J. Pharmacol. Exp. Ther. 289:(1):1999;455-463.
10. Hoffman A.F., van Horne C.G., Eken S., Hoffer B.J., Gerhardt G.A. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF. Exp. Neurol. 147:(1):1997;130-141.
11. Ingram D.K. Age-related decline in physical activity: generalization to nonhumans. Med. Sci. Sports Exerc. 32:(9):2000;1623-1629.
12. Koller W.C., Glatt S., Vetere-Overfield B., Hassanein R. Falls and Parkinson's disease. Clin. Neuropharmacol. 12:(2):1989;98-105.
13. Larsson L., Ramamurthy B. Aging-related changes in skeletal muscles: mechanisms and interventions. Drugs Aging. 17:(4):2000;303-316.
14. Paulson G.W., Schafer K., Hallum B. Avoiding mental changes and falls in older Parkinson's patients. Geriatrics. 41:1986;59-67.
15. Robbins A.S., Rubenstein L.Z., Josephson K.R., Schulman B.L., Osterweil D., Fine G. Predictors of falls among elderly people. Arch. Intern. Med. 149:1989;1628-1633.
16. Stanford J.A., Currier T.D., Gerhardt G.A. Acute locomotor effects of fluoxetine, sertraline and nomifensine in young versus aged Fischer 344 rats, Pharmacol. Biochem. Behav. 71:2002;325-332.
17. Stanford J.A., Hebert M.A., Gerhardt G.A. Biochemical and anatomical changes in basal ganglia of aging animals. Hof P.R., Mobbs C.V., Functional Neurobiology of Aging. 2001;727-736 Academic Press, San Diego, CA.
18. Stoll S., Dorner H., Blosch M., Platt D. Age-dependent differences in the gait of rats. Arch. Gerontol. Geriatr. 10:1990;261-268.
19. Van-der-Zee C.E.E.M., Schuurman T., van-der-Hoop R.G., Traber J., Gispen W.H. Beneficial effect of nimodipine on peripheral nerve function in aged rats. Neurobiol. Aging. 11:1990;451-456.
20. Zigmond M.J. Do compensatory processes underlie the preclinical phase of neurodegenerative disease? insights from an animal model of parkinsonism. Neurobiol. Dis. 4:1997;247-253.